Initiation of psychotropic medication in hospitalized patients with COVID-19: Association with clinical and biological characteristics.

Enrico CapuzziAlice CaldiroliSilvia LeoMassimiliano BuoliMassimo Clerici

Published in: Human psychopharmacology (2021)

Our findings suggest that the initiation of PMs could be common among COVID-19 inpatients. Lymphocyte and platelet counts as well as LDH levels may reflect neuropsychiatric complications of COVID-19.

Keyphrases

coronavirus disease
sars cov
peripheral blood
healthcare
respiratory syndrome coronavirus
risk factors
emergency department
adverse drug